Patent details

Basic Information

Publication number:

EP2887958

PCT Application Number:

US2013055084

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138306220

PCT Publication Number:

WO2014031429

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

LIPOSOME FORMULATIONS

French Title of Invention:

FORMULATIONS LIPOSOMALES

German Title of Invention:

LIPOSOMFORMULIERUNGEN

SPC Number:

Dates

Filing date:

15/08/2013

Grant date:

19/05/2021

EP Publication Date:

01/07/2015

PCT Publication Date:

27/02/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/05/2021

EP B1 Publication Date:

19/05/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/08/2021

Expiration date:

15/08/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/05/2021

 

 

Name:

OPKO Pharmaceuticals, LLC

Address:

4400 Biscayne Boulevard, Miami, FL 33137, United States (US)

Inventor

1

Name:

SANTOS, Arturo

Address:

Mexico (MX)

2

Name:

FROST, Phillip

Address:

United States (US)

Priority

1

Priority Number:

201261691455 P

Priority Date:

21/08/2012

Priority Country:

United States (US)

2

Priority Number:

201361791693 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

3

Priority Number:

201361862300 P

Priority Date:

05/08/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/127; A61K 31/58; A61K 39/395; A61K 39/00;

Publication

European Patent Bulletin

Issue number:

202120

Publication date:

19/05/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages